Abveris offers antibody discovery services using its DiversimAb collection of hyperimmune mouse models, which can be used to develop biologics, according to Twist.

Twist launches new biotech firm
Twist Bioscience has launched a new biotechnology firm, Revelar Biotherapeutics, to develop and market an antibody discovered by Twist that neutralizes...

Twist launches exome panel for genomics research
Twist Bioscience has launched Exome 2.0, an exome panel for genomics research.

Twist Bioscience, Broad Institute partner
Twist Bioscience and the Broad Institute have created a custom next-generation sequencing target enrichment exome panel to be used to research cancer...

Abveris expands antibody discovery offerings with second Beacon system
Abveris has starting using a second Berkeley Lights Beacon optofluidic system to enable expansion of its antibody discovery offerings.

Abveris, Saccharo partner on antibody discovery
Abveris has entered into an antibody discovery partnership with Saccharo for the discovery of monoclonal antibodies to advance Saccharo's immuno-oncology...

Abveris, Immunitas partner on mAbs discovery
Abveris and Immunitas Therapeutics are partnering on the discovery of monoclonal antibodies (mAbs) to expand Immunitas' therapeutic pipeline.